A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study

Mark H. Kirschbaum; Paul Frankel; Timothy W. Synold; Jasmine Zain; David Claxton; Joseph Tuscano; Edward M. Newman; David R Gandara; Primo N Lara

doi:10.1111/bjh.14333

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study

Mark H. Kirschbaum, Paul Frankel, Timothy W. Synold, Jasmine Zain, David Claxton, Joseph Tuscano, Edward M. Newman, David R Gandara, Primo N Lara

Hematology and Oncology

Research output: Contribution to journal › Article

Original language	English (US)
Journal	British Journal of Haematology
DOIs	https://doi.org/10.1111/bjh.14333
State	Accepted/In press - 2016

Keywords

Clinical trials
Myelodysplastic syndrome
Vascular endothelial growth factor

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.14333

Cite this

Kirschbaum, M. H., Frankel, P., Synold, T. W., Zain, J., Claxton, D., Tuscano, J., Newman, E. M., Gandara, D. R., & Lara, P. N. (Accepted/In press). A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study. British Journal of Haematology. https://doi.org/10.1111/bjh.14333

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome : A California Cancer Consortium Study. / Kirschbaum, Mark H.; Frankel, Paul; Synold, Timothy W.; Zain, Jasmine; Claxton, David; Tuscano, Joseph; Newman, Edward M.; Gandara, David R ; Lara, Primo N.

In: British Journal of Haematology, 2016.

Research output: Contribution to journal › Article

Kirschbaum, Mark H. ; Frankel, Paul ; Synold, Timothy W. ; Zain, Jasmine ; Claxton, David ; Tuscano, Joseph ; Newman, Edward M. ; Gandara, David R ; Lara, Primo N. / A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome : A California Cancer Consortium Study. In: British Journal of Haematology. 2016.

@article{3a9ad6cc23374cdab037c2c3b2659ee5,

title = "A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: A California Cancer Consortium Study",

keywords = "Clinical trials, Myelodysplastic syndrome, Vascular endothelial growth factor",

author = "Kirschbaum, {Mark H.} and Paul Frankel and Synold, {Timothy W.} and Jasmine Zain and David Claxton and Joseph Tuscano and Newman, {Edward M.} and Gandara, {David R} and Lara, {Primo N}",

year = "2016",

doi = "10.1111/bjh.14333",

language = "English (US)",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome

T2 - A California Cancer Consortium Study

AU - Kirschbaum, Mark H.

AU - Frankel, Paul

AU - Synold, Timothy W.

AU - Zain, Jasmine

AU - Claxton, David

AU - Tuscano, Joseph

AU - Newman, Edward M.

AU - Gandara, David R

AU - Lara, Primo N

PY - 2016

Y1 - 2016

KW - Clinical trials

KW - Myelodysplastic syndrome

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=84997611337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997611337&partnerID=8YFLogxK

U2 - 10.1111/bjh.14333

DO - 10.1111/bjh.14333

M3 - Article

C2 - 27650362

AN - SCOPUS:84997611337

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -